Physician profile
Raja Dhalla
NPI 1730157876
$953.17
in general payments reported to CMS, 2019-2025
10 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2022: $98.68 · 2023: $133 · 2024: $88.65 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $253.06 | 2022-2025 | Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate, Xcell |
| Stryker Corporation | $169.33 | 2019-2023 | Variax |
| Wright Medical Technology, INC. | $168.93 | 2019 | |
| Arthrex, INC. | $140.37 | 2019 | |
| Depuy Synthes Sales INC. | $64.88 | 2025 | Truespan Orthocord, Dynatape, Vapr |
| Zimmer Biomet Holdings, INC. | $46.36 | 2023-2024 | Persona |
| Agiliti Health, INC. | $41.61 | 2025 | Konica Minolta - Kdr Advanced U-Arm |
| Aroa Biosurgery Incorporated | $27.77 | 2023 | |
| Linvatec Corporation | $25.26 | 2019 | |
| Molnlycke Health Care US, LLC | $15.60 | 2024 | Avance, Mepilex Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raja Dhalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.